1u21
From Proteopedia
(New page: 200px<br /> <applet load="1u21" size="450" color="white" frame="true" align="right" spinBox="true" caption="1u21, resolution 1.69Å" /> '''transthyretin with ...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1u21.gif|left|200px]]<br /> | + | [[Image:1u21.gif|left|200px]]<br /><applet load="1u21" size="350" color="white" frame="true" align="right" spinBox="true" |
| - | <applet load="1u21" size=" | + | |
caption="1u21, resolution 1.69Å" /> | caption="1u21, resolution 1.69Å" /> | ||
'''transthyretin with tethered inhibitor on one monomer.'''<br /> | '''transthyretin with tethered inhibitor on one monomer.'''<br /> | ||
==Overview== | ==Overview== | ||
| - | Protein native state stabilization imposed by small molecule binding is an | + | Protein native state stabilization imposed by small molecule binding is an attractive strategy to prevent the misfolding and misassembly processes associated with amyloid diseases. Transthyretin (TTR) amyloidogenesis requires rate-limiting tetramer dissociation before misassembly of a partially denatured monomer ensues. Selective stabilization of the native TTR tetramer over the dissociative transition state by small molecule binding to both thyroxine binding sites raises the kinetic barrier of tetramer dissociation, preventing amyloidogenesis. Assessing the amyloidogenicity of a TTR tetramer having only one amyloidogenesis inhibitor (I) bound is challenging because the two small molecule binding constants are generally not distinct enough to allow for the exclusive formation of TTR.I in solution to the exclusion of TTR.I(2) and unliganded TTR. Herein, we report a method to tether one fibril formation inhibitor to TTR by disulfide bond formation. Occupancy of only one of the two thyroxine binding sites is sufficient to inhibit tetramer dissociation in 6.0 M urea and amyloidogenesis under acidic conditions by imposing kinetic stabilization on the entire tetramer. The sufficiency of single occupancy for stabilizing the native state of TTR provides the incentive to search for compounds displaying striking negative binding cooperativity (e.g., K(d1) in nanomolar range and K(d2) in the micromolar to millimolar range), enabling lower doses of inhibitor to be employed in the clinic, mitigating potential side effects. |
==Disease== | ==Disease== | ||
| Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
| - | 1U21 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with P2C as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | + | 1U21 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=P2C:'>P2C</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1U21 OCA]. |
==Reference== | ==Reference== | ||
| Line 18: | Line 17: | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Foss, T.]] | [[Category: Foss, T.]] | ||
| - | [[Category: Johnson, S | + | [[Category: Johnson, S M.]] |
| - | [[Category: Kelker, M | + | [[Category: Kelker, M S.]] |
| - | [[Category: Kelly, J | + | [[Category: Kelly, J W.]] |
| - | [[Category: Wilson, I | + | [[Category: Wilson, I A.]] |
| - | [[Category: Wiseman, R | + | [[Category: Wiseman, R L.]] |
[[Category: P2C]] | [[Category: P2C]] | ||
[[Category: amyloid]] | [[Category: amyloid]] | ||
[[Category: transthyretin]] | [[Category: transthyretin]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:19:48 2008'' |
Revision as of 13:19, 21 February 2008
|
transthyretin with tethered inhibitor on one monomer.
Contents |
Overview
Protein native state stabilization imposed by small molecule binding is an attractive strategy to prevent the misfolding and misassembly processes associated with amyloid diseases. Transthyretin (TTR) amyloidogenesis requires rate-limiting tetramer dissociation before misassembly of a partially denatured monomer ensues. Selective stabilization of the native TTR tetramer over the dissociative transition state by small molecule binding to both thyroxine binding sites raises the kinetic barrier of tetramer dissociation, preventing amyloidogenesis. Assessing the amyloidogenicity of a TTR tetramer having only one amyloidogenesis inhibitor (I) bound is challenging because the two small molecule binding constants are generally not distinct enough to allow for the exclusive formation of TTR.I in solution to the exclusion of TTR.I(2) and unliganded TTR. Herein, we report a method to tether one fibril formation inhibitor to TTR by disulfide bond formation. Occupancy of only one of the two thyroxine binding sites is sufficient to inhibit tetramer dissociation in 6.0 M urea and amyloidogenesis under acidic conditions by imposing kinetic stabilization on the entire tetramer. The sufficiency of single occupancy for stabilizing the native state of TTR provides the incentive to search for compounds displaying striking negative binding cooperativity (e.g., K(d1) in nanomolar range and K(d2) in the micromolar to millimolar range), enabling lower doses of inhibitor to be employed in the clinic, mitigating potential side effects.
Disease
Known diseases associated with this structure: Amyloid neuropathy, familial, several allelic types OMIM:[176300], Amyloidosis, senile systemic OMIM:[176300], Carpal tunnel syndrome, familial OMIM:[176300], Dystransthyretinemic hyperthyroxinemia OMIM:[176300]
About this Structure
1U21 is a Single protein structure of sequence from Homo sapiens with as ligand. Full crystallographic information is available from OCA.
Reference
Kinetic stabilization of an oligomeric protein by a single ligand binding event., Wiseman RL, Johnson SM, Kelker MS, Foss T, Wilson IA, Kelly JW, J Am Chem Soc. 2005 Apr 20;127(15):5540-51. PMID:15826192
Page seeded by OCA on Thu Feb 21 15:19:48 2008
Categories: Homo sapiens | Single protein | Foss, T. | Johnson, S M. | Kelker, M S. | Kelly, J W. | Wilson, I A. | Wiseman, R L. | P2C | Amyloid | Transthyretin
